[
  {
    "ts": "2025-10-08T21:07:00+00:00",
    "headline": "Top Stock Reports for SAP, Novartis & Philip Morris",
    "summary": "SAP, Novartis and Philip Morris headline today's top Zacks reports, each showing strong momentum and strategic growth drivers despite industry headwinds.",
    "url": "https://finance.yahoo.com/news/top-stock-reports-sap-novartis-210700201.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "2d6bf611-c25a-332f-8f05-ce4adf83ea58",
      "content": {
        "id": "2d6bf611-c25a-332f-8f05-ce4adf83ea58",
        "contentType": "STORY",
        "title": "Top Stock Reports for SAP, Novartis & Philip Morris",
        "description": "",
        "summary": "SAP, Novartis and Philip Morris headline today's top Zacks reports, each showing strong momentum and strategic growth drivers despite industry headwinds.",
        "pubDate": "2025-10-08T21:07:00Z",
        "displayTime": "2025-10-08T21:07:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/96776645e0ac7ab203b7d5e3b37251a6",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kOx_hEoutoKbvEBeeXdzsA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/96776645e0ac7ab203b7d5e3b37251a6.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/F9I2cfbMe3krq0DVrblX.g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/96776645e0ac7ab203b7d5e3b37251a6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-stock-reports-sap-novartis-210700201.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-stock-reports-sap-novartis-210700201.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "UBER"
            },
            {
              "symbol": "SAP"
            },
            {
              "symbol": "SAPGF"
            },
            {
              "symbol": "NET"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "NVSEF"
            },
            {
              "symbol": "PM"
            },
            {
              "symbol": "SAP.DE"
            },
            {
              "symbol": "NOVN.SW"
            },
            {
              "symbol": "ICCC"
            },
            {
              "symbol": "CLRO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-08T14:51:00+00:00",
    "headline": "Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product",
    "summary": "STAMFORD, CT, October 08, 2025--Experts from Philip Morris International Inc. (NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific researchers, provides nonbinding recommendations to the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP).",
    "url": "https://finance.yahoo.com/news/philip-morris-international-urges-u-145100654.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "f56da302-24fb-3f43-a21d-aa99473569e9",
      "content": {
        "id": "f56da302-24fb-3f43-a21d-aa99473569e9",
        "contentType": "STORY",
        "title": "Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product",
        "description": "",
        "summary": "STAMFORD, CT, October 08, 2025--Experts from Philip Morris International Inc. (NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific researchers, provides nonbinding recommendations to the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP).",
        "pubDate": "2025-10-08T14:51:00Z",
        "displayTime": "2025-10-08T14:51:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/eab67409f99698c330c71ca38701de2d",
          "originalWidth": 3543,
          "originalHeight": 612,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bCw5b78wCC6HQewitxdMYg--~B/aD02MTI7dz0zNTQzO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/eab67409f99698c330c71ca38701de2d.cf.webp",
              "width": 3543,
              "height": 612,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OifMGp0Ah61jWYovcHGNwQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/eab67409f99698c330c71ca38701de2d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/philip-morris-international-urges-u-145100654.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/philip-morris-international-urges-u-145100654.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PMI"
            },
            {
              "symbol": "PM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-08T14:20:00+00:00",
    "headline": "MO's on! Hits 8.7% Oral Tobacco Share: Can It Fend Off Competitors?",
    "summary": "Altria's on! nicotine pouch brand captures 8.7% of the U.S. oral tobacco market, fueling growth and brand momentum in a fierce competitive landscape.",
    "url": "https://finance.yahoo.com/news/mos-hits-8-7-oral-142000758.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "9c22d768-cbbe-3048-87f7-f0c08f4bcfd0",
      "content": {
        "id": "9c22d768-cbbe-3048-87f7-f0c08f4bcfd0",
        "contentType": "STORY",
        "title": "MO's on! Hits 8.7% Oral Tobacco Share: Can It Fend Off Competitors?",
        "description": "",
        "summary": "Altria's on! nicotine pouch brand captures 8.7% of the U.S. oral tobacco market, fueling growth and brand momentum in a fierce competitive landscape.",
        "pubDate": "2025-10-08T14:20:00Z",
        "displayTime": "2025-10-08T14:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1aaeef9760d687a7af088e5f14dc00",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BsEi4ucCrr2k82dqEATKVA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1aaeef9760d687a7af088e5f14dc00.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gHmcE.tLgqkRYCjUZ.wyog--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1aaeef9760d687a7af088e5f14dc00.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mos-hits-8-7-oral-142000758.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mos-hits-8-7-oral-142000758.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TPB"
            },
            {
              "symbol": "PM"
            },
            {
              "symbol": "MO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]